TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 3 | 3 | 2 | 11 | 8 | 22 | 52 | 16 |
| P | %wins | 100 | 67 | 100 | 33 | 67 | 67 | 72 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/29/12 19:15 | 11/29/12 | HALO | Halozyme Therapeutics Inc | DE | Health | BioPrd | Biological Products, (No Diag | Engler Robert | CA | D | P | 84 | 5.57 | 3 | 15 | 10 | 165 | D | -22 | -32 | -33 | -4 | -10 | 7 | 4 | -4 | 9 | 3 | 17 | -4 | 25 | 168 | |
11/15/11 16:40 | 11/14/11 | HALO | Halozyme Therapeutics Inc | DE | Health | BioPrd | Biological Products, (No Diag | Engler Robert | CA | D | P | 41 | 8.15 | 8 | 5 | 4 | 130 | D | 21 | 10 | 24 | 24 | 34 | -1 | -4 | -2 | 0 | -2 | 11 | 38 | -9 | -35 | |
12/18/08 16:46 | 12/16/08 | HALO | Halozyme Therapeutics Inc | DE | Health | BioPrd | Biological Products, (No Diag | Engler Robert | CA | D | P | 44 | 4.38 | 1 | 10 | 18 | 65 | D | -31 | -25 | -21 | -36 | 7 | 34 | 36 | 7 | 1 | 5 | 6 | -11 | 50 | 22 | |
5/25/05 11:57 | 5/24/05 | HTI | Halozyme Therapeutics Inc | NV | Health | BioPrd | Biological Products, (No Diag | Engler Robert | CA | D | P | 49 | 1.95 | 0 | 25 | 250 | 35 | D | |||||||||||||||
8/18/04 19:45 | 8/18/04 | HZYM | Halozyme Therapeutics Inc | NV | Health | BioPrd | Biological Products, (No Diag | Engler Robert L Md | CA | D | P | 16 | 1.60 | 0 | 10 | New | 10 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |